BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bondeelle L, Bergeron A. Managing pulmonary complications in allogeneic hematopoietic stem cell transplantation. Expert Rev Respir Med 2019;13:105-19. [PMID: 30523731 DOI: 10.1080/17476348.2019.1557049] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Alam W, Mohamad R, Koubaissi M, Koubaissi SA. Fibrotic Cystic Lung Disease Post Hematopoietic Stem Cell Transplant: Who is the Culprit? Clin Med Insights Case Rep 2022;15:11795476221097317. [PMID: 35591973 DOI: 10.1177/11795476221097317] [Reference Citation Analysis]
2 Busmail A, Penumetcha SS, Ahluwalia S, Irfan R, Khan SA, Rohit Reddy S, Vasquez Lopez ME, Zahid M, Mohammed L. A Systematic Review on Pulmonary Complications Secondary to Hematopoietic Stem Cell Transplantation. Cureus. [DOI: 10.7759/cureus.24807] [Reference Citation Analysis]
3 Kunihiro Y, Tanaka N, Kawano R, Yujiri T, Ueda K, Gondo T, Kobayashi T, Matsumoto T, Ito K. High-resolution CT findings of pulmonary infections in patients with hematologic malignancy: comparison between patients with or without hematopoietic stem cell transplantation. Jpn J Radiol. [DOI: 10.1007/s11604-022-01260-7] [Reference Citation Analysis]
4 Fitch T, Myers KC, Dewan M, Towe C, Dandoy C. Pulmonary Complications After Pediatric Stem Cell Transplant. Front Oncol 2021;11:755878. [PMID: 34722309 DOI: 10.3389/fonc.2021.755878] [Reference Citation Analysis]
5 Astashchanka A, Ryan J, Lin E, Nokes B, Jamieson C, Kligerman S, Malhotra A, Mandel J, Joshua J. Pulmonary Complications in Hematopoietic Stem Cell Transplant Recipients-A Clinician Primer. J Clin Med 2021;10:3227. [PMID: 34362012 DOI: 10.3390/jcm10153227] [Reference Citation Analysis]
6 Cao LQ, Zhou JR, Zhang XH, Xu LP, Wang Y, Chen YH, Chen H, Chen Y, Han W, Yan CH, Zhang YY, Wang FR, Kong J, Wang ZD, Cheng YF, Wang JZ, Mo XD, Han TT, Zhao XS, Chang YJ, Liu KY, Huang XJ, Sun YQ. A Scoring System for Predicting the Prognosis of Late-Onset Severe Pneumonia after Allogeneic Hematopoietic Stem Cell Transplantation. Transplant Cell Ther 2021:S2666-6367(21)01034-4. [PMID: 34229053 DOI: 10.1016/j.jtct.2021.06.031] [Reference Citation Analysis]
7 Kouroki M, Inagaki J, Fujisaki T, Matsuishi T, Sato T, Kamizono J, Yasui M. Nintedanib for treatment of progressive interstitial lung disease after peripheral blood stem cell transplantation in a patient with recurrent acute lymphoblastic leukemia. Pediatr Blood Cancer 2021;:e29211. [PMID: 34197046 DOI: 10.1002/pbc.29211] [Reference Citation Analysis]
8 Bos S, De Sadeleer LJ, Vanstapel A, Beeckmans H, Sacreas A, Yserbyt J, Wuyts WA, Vos R. Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review. Eur Respir Rev 2021;30:210050. [PMID: 34415849 DOI: 10.1183/16000617.0050-2021] [Reference Citation Analysis]
9 Riddell P, Vasudevan-Nampoothiri R, Ma J, Singer LG, Lipton JH, Juvet SC. Lung transplantation for late-onset non-infectious chronic pulmonary complications of allogenic hematopoietic stem cell transplant. Respir Res 2021;22:101. [PMID: 33827576 DOI: 10.1186/s12931-021-01699-8] [Reference Citation Analysis]
10 Bondeelle L, Chevret S, Hurabielle C, Samy L, Goletto T, Costantini A, Sicre de Fontbrune F, Michonneau D, Socié G, Tazi A, Bouaziz JD, Bergeron A. Effect of Ruxolitinib on Lung Function after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant 2020;26:2115-20. [PMID: 32738501 DOI: 10.1016/j.bbmt.2020.07.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Saunders IM, Tan M, Koura D, Young R. Long-term Follow-up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics. Pharmacotherapy 2020;40:808-41. [PMID: 32652612 DOI: 10.1002/phar.2443] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]